BLADDER - URINARY FUNCTIONS

BLADDER - URINARY FUNCTIONS:

• 2020
• Analgesic prescribing habits and patterns of Canadian chief urology residents: A national survey. (Canada, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31977305/ 
• Marijuana, lower urinary tract symptoms, and pain in the urologic patient. (USA, abstract, 2020) https://www.goldjournal.net/article/S0090-4295(20)30113-8/fulltext 
• 2019
• A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria. (USA, link to full, 2019) https://www.hindawi.com/journals/crim/2019/6327819/ 
• Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats. (Portugal/ UK, abstract, 2019) https://link.springer.com/article/10.1007%2Fs00210-019-01729-9 
• Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men. (Japan, abstract, 2019) https://link.springer.com/article/10.1007%2Fs00345-019-02647-4 
• 2018
• Always Need to Go? Try Cannabis for Urinary Incontinence. (news – 2018)
  https://www.hellomd.com/health-wellness/5b4586c38904b90007731ace/always-need-to-go-try-cannabis-for-urinary-incontinence
• Potential of Endocannabinoids to Control Bladder Pain. (USA, full, 2018) https://www.frontiersin.org/articles/10.3389/fnsys.2018.00017/full 
• The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis. (UK, full, 2018) https://link.springer.com/article/10.1007%2Fs11910-018-0857-z 
• Are the therapeutic qualities of cannabis reinforcing its abuse? A case report. (India, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241198/ 
• MODULATION OF MEAN ARTERIAL PRESSURE AND DIURESIS BY RENOMEDULLARY INFUSION OF A SELECTIVE INHIBITOR OF FATTY ACID AMIDE HYDROLASE. (USA, full, 2018) https://journals.physiology.org/doi/full/10.1152/ajprenal.00090.2018?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org& 
• An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois. (USA, full, 2018) https://www.nejm.org/doi/full/10.1056/NEJMoa1807652 
• Psychosis and synthetic cannabinoids. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0165178117314312?via%3Dihub 
• 2017
• Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats. (Republic of Korea, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747270/ 
• Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. (Switzerland/ France/ UK, full, 2017) https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1111/bju.13759 
• Impact of Regular Cannabis Use on Biomarkers of Lower Urinary Tract Function. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541002/ 
• Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the FructoseFed Rats. (Taiwan, abstract, 2017) https://www.semanticscholar.org/paper/Metabolic-Syndrome-Induced-Bladder-Cannabinoid-in-Chen-Cheng/9d4f4f12cea51fd1366412098dcd96e2e3553b75 
• THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study. (Italy, abstract, 2017) https://link.springer.com/article/10.1007%2Fs10072-017-3148-6 
• 2016
• Cannabis as a Treatment for Overactive Bladder and Incontinence (news–2016)
  https://www.marijuanatimes.org/cannabis-as-a-treatment-for-overactive-bladder-and-incontinence/
• Reiters Syndrome and Medical Marijuana. (news – 2016)
  https://www.medicalmarijuanablog.com/benefits-category/reiters-syndrome-medical-marijuana.html
• New therapeutic strategies for the treatment of male lower urinary tract symptoms. (Greece, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853157/ 
• Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors. (Spain, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/ 
• Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959092/ 
• Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374309/ 
• Potential Future Pharmacological Treatment of Bladder Dysfunction. (USA/ Denmark, full, 2016) https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.12577 
• Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity. (USA, full, 2016) https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1111/bju.13336 
• Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. (UK, abstract, 2016) https://link.springer.com/article/10.1007/s00192-016-2984-x 
• Anandamide transporter-mediated regulation of the micturition reflex in urethaneanesthetized rats. (Japan/ USA, abstract, 2016) https://link.springer.com/article/10.1007/s11255-016-1329-5 
• The endocannabinoid system - a target for the treatment of LUTS? (Sweden/ Germany, abstract, 2016) https://www.nature.com/articles/nrurol.2016.110 
• 2015
• Here’s What Marijuana Does To Your Bladder. (news – 2015)
  https://archive.attn.com/stories/2522/marijuana-does-to-your-bladder
• Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/ 
• URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechanoafferent nerve fibers in rats. (Japan/ Sweden/ Italy, full, 2015) https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1111/bju.13223 
• Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339033/ 
• Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol. (Italy/ USA, link to PDF, 2015) https://www.researchgate.net/publication/280391642_Effect_of_Non-psychotropic_Plant-derived_Cannabinoids_on_Bladder_Contractility_Focus_on_Cannabigerol 
• Endocannabinoids and the Digestive Tract and Bladder in Health and Disease. (UK, partial preview, 2015) https://books.google.com/books?hl=en&lr=&id=QwihCgAAQBAJ&oi=fnd&pg=PA392&ots=FMMqEBDUlA&sig=rRXLCR-WXtY956wHaCOJXuECrT0#v=onepage&q&f=false 
• Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats. (Germany/ Italy/ Sweden, abstract, 2015) https://www.semanticscholar.org/paper/Spinal-neuronal-cannabinoid-receptors-mediate-of-in-Fuellhase-Schreiber/b51a4ef67ea5b2fd72f077e6f48e4ed1e7202efe 
• Cannabinoid receptor expression in the bladder is altered in detrusor overactivity. (UK, abstract, 2015) https://www.semanticscholar.org/paper/Cannabinoid-receptor-expression-in-the-bladder-is-Bakali-Mcdonald/551599e4c73dcbde89f5ea89ec0db9f011420b8c 
• The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats. (Poland, abstract, 2015) https://www.semanticscholar.org/paper/The-role-of-the-peripheral-cannabinoid-system-in-of-Juszczak-Maciukiewicz/e0339c8000195e298d3ef04be25a0ee098698288 
• 2011
• Severity of acute cystitis may be cut with cannabinoid agonist (news – forum re-post – 2011) https://forum.grasscity.com/threads/severity-of-acute-cystitis-may-be-cut-with-cannabinoid-agonist.1463384/#post-23639559
• Undated
• Medical marijuana for shingles. (news – undated)
  http://www.thetruthaboutshingles.com/2013/02/smoking-pot-no-help-for-shingles.html